During Santexpo Paris, a strategic agreement was signed between Evolucare and the Lebanese group FATTAL. It is the culmination of several months of preparation and collaboration between the two entities, with a common ambition of success in the Middle East markets.
Fattal is a major Lebanese group operating in various sectors including healthcare: pharmaceutical products, medical equipment, and of course healthcare IT with strong experience around radiology. With nearly 2900 employees and more than 850 million US Dollars in revenues, it is a strong ally for Evolucare in the Middle East.
The two partners share the same ambition: for Evolucare, (it is) to have a powerful relay in the region to market and implement its solutions; for Fattal, (the objective is) to complete its digital offer in order to reinforce its presence in the various markets in the Arab world – an important opportunity given the current difficulties of its domestic market.
The Lebanese company has a unit dedicated to healthcare whose multidisciplinary staff is fluent in Arabic, French and English. This unit is able to take on the new functional horizons offered by Evolucare range and technological ones – as – artificial intelligence, which we are increasingly implementing in our solutions andwhich demand is increasing dramatically in the Gulf countries.
A commercial and technical agreement
The formalized collaboration between the two companies goes beyond a simple distribution agreement. This aspect is present and Fattal is strengthening its sales teams in territories such as Iraq, the Emirates and other Gulf countries.
But in order to offer an efficient system in this region, the contract also covers a transfer of skills that will enable Fattal to ensure an increasing part of the implementation of the solutions as well as their first-level support. This provides Evolucare teams in France with more flexibility and efficiency but most importantly a better global service to local customers.